Disubstituted sialic acid ligands targeting siglecs CD33 and CD22 associated with myeloid leukaemias and B cell lymphomas
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Disubstituted sialic acid ligands targeting siglecs CD33 and CD22 associated with myeloid leukaemias and B cell lymphomas
Authors
Keywords
-
Journal
Chemical Science
Volume 5, Issue 6, Pages 2398
Publisher
Royal Society of Chemistry (RSC)
Online
2014-03-31
DOI
10.1039/c4sc00451e
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- On-Chip Synthesis and Screening of a Sialoside Library Yields a High Affinity Ligand for Siglec-7
- (2013) Cory D. Rillahan et al. ACS Chemical Biology
- C-4 Modified Sialosides Enhance Binding to Siglec-2 (CD22): Towards Potent Siglec Inhibitors for Immunoglycotherapy
- (2013) Sørge Kelm et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Targeting CD22 in B-cell Malignancies: Current Status and Clinical Outlook
- (2013) Loretta Sullivan-Chang et al. BIODRUGS
- Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis
- (2013) Matthew S. Macauley et al. JOURNAL OF CLINICAL INVESTIGATION
- Copresentation of Antigen and Ligands of Siglec-G Induces B Cell Tolerance Independent of CD22
- (2013) F. Pfrengle et al. JOURNAL OF IMMUNOLOGY
- CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
- (2013) Elizabeth M Bradshaw et al. NATURE NEUROSCIENCE
- Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
- (2013) Ana Griciuc et al. NEURON
- Targeted delivery of lipid antigen to macrophages via the CD169/sialoadhesin endocytic pathway induces robust invariant natural killer T cell activation
- (2013) N. Kawasaki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Click and Pick: Identification of Sialoside Analogues for Siglec-Based Cell Targeting
- (2012) Cory D. Rillahan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Acute myeloid leukemia stem cells and CD33-targeted immunotherapy
- (2012) R. B. Walter et al. BLOOD
- Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia
- (2012) Robert J. Kreitman et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia
- (2012) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- In Silico-Aided Design of a Glycan Ligand of Sialoadhesin for in Vivo Targeting of Macrophages
- (2012) Corwin M. Nycholat et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
- (2012) Sylvie Castaigne et al. LANCET
- Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study
- (2012) Hagop Kantarjian et al. LANCET ONCOLOGY
- Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions
- (2012) Takumi Kiwamoto et al. PHARMACOLOGY & THERAPEUTICS
- Targeting Siglecs—A novel pharmacological strategy for immuno- and glycotherapy
- (2011) Camilla Jandus et al. BIOCHEMICAL PHARMACOLOGY
- CD22-Antagonists with nanomolar potency: The synergistic effect of hydrophobic groups at C-2 and C-9 of sialic acid scaffold
- (2011) Hajjaj H.M. Abdu-Allah et al. BIOORGANIC & MEDICINAL CHEMISTRY
- High affinity sialoside ligands of myelin associated glycoprotein
- (2011) Ying Zeng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- From a Library of MAG Antagonists to Nanomolar CD22 Ligands
- (2011) Stefanie Mesch et al. ChemMedChem
- A Sialylated Glycan Microarray Reveals Novel Interactions of Modified Sialic Acids with Proteins and Viruses
- (2011) Xuezheng Song et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
- (2011) Adam C Naj et al. NATURE GENETICS
- In vivo targeting of B-cell lymphoma with glycan ligands of CD22
- (2010) W. C. Chen et al. BLOOD
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- (2010) Michinori Ogura et al. CANCER SCIENCE
- Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study
- (2010) Anjali Advani et al. JOURNAL OF CLINICAL ONCOLOGY
- CD22 Is a Recycling Receptor That Can Shuttle Cargo between the Cell Surface and Endosomal Compartments of B Cells
- (2010) M. K. O'Reilly et al. JOURNAL OF IMMUNOLOGY
- Low Molecular Weight Antagonists of the Myelin-Associated Glycoprotein: Synthesis, Docking, and Biological Evaluation
- (2010) Stefanie Mesch et al. JOURNAL OF MEDICINAL CHEMISTRY
- Basic and Clinical Immunology of Siglecs
- (2009) Stephan von Gunten et al. Annals of the New York Academy of Sciences
- Potent small molecule mouse CD22-inhibitors: Exploring the interaction of the residue at C-2 of sialic acid scaffold
- (2009) Hajjaj H.M. Abdu-Allah et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo
- (2009) Bao Hoa Duong et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Siglecs as targets for therapy in immune-cell-mediated disease
- (2009) Mary K. O’Reilly et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Design, Synthesis, and Structure−Affinity Relationships of Novel Series of Sialosides as CD22-Specific Inhibitors
- (2008) Hajjaj H. M. Abdu-Allah et al. JOURNAL OF MEDICINAL CHEMISTRY
- Sialoside Analogue Arrays for Rapid Identification of High Affinity Siglec Ligands
- (2008) Ola Blixt et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now